MoneyWorks4Me

The revenue zoomed 6.44% to Rs. 814.95 millions for the quarter ended December 2023 as compared to Rs. 765.63 millions during the corresponding quarter last year.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 12.57  millions as against Rs. 14.69 millions reported during the corresponding quarter ended.Operating profit surged to 78.86 millions from the corresponding previous quarter of 70.75 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 814.95 765.63 6.44 2439.60 2211.27 10.33 3030.99 2803.65 8.11
Other Income 2.57 7.72 -66.71 11.17 17.16 -34.91 21.55 64.90 -66.80
PBIDT 78.86 70.75 11.46 232.43 194.76 19.34 281.87 296.92 -5.07
Interest 36.61 31.18 17.42 111.18 83.18 33.66 121.56 103.99 16.90
PBDT 42.25 39.57 6.77 121.25 111.58 8.67 160.31 192.93 -16.91
Depreciation 25.51 20.26 25.91 66.88 58.18 14.95 74.81 72.37 3.37
PBT 16.74 19.31 -13.31 54.37 53.40 1.82 85.50 120.56 -29.08
TAX 4.17 4.62 -9.74 13.83 13.34 3.67 24.23 34.77 -30.31
Deferred Tax -2.38 -3.10 -23.23 -7.98 -14.12 -43.48 3.92 -19.38 -120.23
PAT 12.57 14.69 -14.43 40.54 40.06 1.20 61.27 85.79 -28.58
Equity 158.04 156.90 0.73 158.04 156.90 0.73 156.90 148.22 5.86
PBIDTM(%) 9.68 9.24 4.72 9.53 8.81 8.17 9.30 10.59 -12.19
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..